Laura Melendez-Alafort

22PUBLICATIONS
48CO-AUTHORS
Radiation therapyAcceleratorsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 30, 2025
Enhancing Cytosolic Internalization of [177Lu]Lu-iPSMA in Prostate Cancer Cells: The Effect of Conjugating a GRP78 Inhibitor to the Radiotherapeutic Molecule.

Erika Azorín-Vega, Daniel García-Arce, Myrna Luna-Gutiérrez

|Sep 16, 2025
Assessment of the impact of the nuclear properties ofβ--emitting radionuclides on the dosimetry of two radiopharmaceuticals with distinct pharmacokinetics.

Laura De Nardo, Samuele De Zan, Kevin J H Allen

|Jul 30, 2025
Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.

Guillermina Ferro-Flores, Myrna Luna-Gutiérrez, Blanca Ocampo-García

|Jul 29, 2025
Correction to "In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy".

Kevin J H Allen, Connor Frank, Rubin Jiao

|Jul 29, 2025
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose.

Guillermina Ferro-Flores, Erika Azorín-Vega, Blanca Ocampo-García

|Jan 22, 2025
Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy.

Myrna Luna-Gutiérrez, Erika Azorín-Vega, Rigoberto Oros-Pantoja

Pageof 4

Frequent Collaborators

9 joint publications

Guillermina Ferro-Flores

9 joint publications

Blanca Ocampo-García

7 joint publications

Laura De Nardo

6 joint publications

Antonio Rosato